Post Reply
121-140 of 235
I' m still waiting to see who is the buyer of 40m shares on last Thurs. It could be a retailer bah. Not expensive anyways?
darkhorse88 ( Date: 18-Nov-2020 10:08) Posted:
|
isit?? ahha
darkhorse88 ( Date: 18-Nov-2020 10:08) Posted:
|
Wait for announcement this 2 days for change in Director Interest. This company do not have any BB at all.
try try
If there's no announcement by next Tuesday, safe to say someone (retailer/shy BB) bought 40m shares.
darkhorse88 ( Date: 13-Nov-2020 12:23) Posted:
|
While you posted this, yesterday volume should be another buy by Date or his another major shareholder.
Just wait for SGX announcement. It's always delayed.
TheMysteryDay024 ( Date: 12-Nov-2020 17:46) Posted:
|
COPY PASTE FROM INVESTINGNOTE
If you believe in a business that deals with high-end cosmetic surgery, this is a multi-bagger stock you perhaps wouldn' t want to miss. Beverly JCG (formerly known as JCG-Investments) has taken a new business direction since 2019:
1) Beverly JCG acquired a controlling interest in Beverly Wilshire Medical Centre Group on 7 November 2019. This brings to the Group an established player in Malaysia in the healthcare industry with their core business in medical and dental aesthetics, healthy ageing wellness and regenerative therapies, cosmetic surgery and hair restoration. Beverly Wilshire is a multi-award-winning integrated beauty care and medical aesthetics group established in 2012. It manages and operates two (2) fully-licensed Ministry of Health of Malaysia medical centres, in addition to three (3) licenced aesthetics clinics in Kuala Lumpur, Petaling Jaya and Johore Bahru.
2) The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd has on 24 January 2020, formed a strategic joint venture with Natasha Skincare (Malaysia) Sdn Bhd under a SPV, Natasha Beverly Sdn Bhd. The joint venture&rsquo s principal activities will include a medical aesthetics clinic and other health maintenance procedures such as medi-spa, chiropractor and physiotheraphy. Natasha Skincare is a leading beauty brand in Indonesia with more than 100 outlets. The joint venture will positively benefit JCG. Natasha Beverly has since become operational on 15 October 2020.
3) Board of Directors and Key Executives have started buying back shares at $0.001 since 06 October 2020. This suggests some confidence and actions for the stock price soon.
I' ve loaded at $0.001 because the business prospects appeal to me, and at the same time, I am certain that the demand for cosmetic surgery would always been there. Again, Beverly Wilshire Medical Centre is not any low-tier branding, it is a premium cosmetic medical centre. The downside is limited for NOW.
Just remember, there' s always demand no matter how ridiculously cosmetic surgery are priced because there are people who are willing and can afford it.
If you have some spare cash, looking for a 100% return, why not this stock? Of course, invest what you are prepared to lose. DYODD. (:
If you believe in a business that deals with high-end cosmetic surgery, this is a multi-bagger stock you perhaps wouldn' t want to miss. Beverly JCG (formerly known as JCG-Investments) has taken a new business direction since 2019:
1) Beverly JCG acquired a controlling interest in Beverly Wilshire Medical Centre Group on 7 November 2019. This brings to the Group an established player in Malaysia in the healthcare industry with their core business in medical and dental aesthetics, healthy ageing wellness and regenerative therapies, cosmetic surgery and hair restoration. Beverly Wilshire is a multi-award-winning integrated beauty care and medical aesthetics group established in 2012. It manages and operates two (2) fully-licensed Ministry of Health of Malaysia medical centres, in addition to three (3) licenced aesthetics clinics in Kuala Lumpur, Petaling Jaya and Johore Bahru.
2) The Company&rsquo s wholly-owned subsidiary JCG-Beverly Pte Ltd has on 24 January 2020, formed a strategic joint venture with Natasha Skincare (Malaysia) Sdn Bhd under a SPV, Natasha Beverly Sdn Bhd. The joint venture&rsquo s principal activities will include a medical aesthetics clinic and other health maintenance procedures such as medi-spa, chiropractor and physiotheraphy. Natasha Skincare is a leading beauty brand in Indonesia with more than 100 outlets. The joint venture will positively benefit JCG. Natasha Beverly has since become operational on 15 October 2020.
3) Board of Directors and Key Executives have started buying back shares at $0.001 since 06 October 2020. This suggests some confidence and actions for the stock price soon.
I' ve loaded at $0.001 because the business prospects appeal to me, and at the same time, I am certain that the demand for cosmetic surgery would always been there. Again, Beverly Wilshire Medical Centre is not any low-tier branding, it is a premium cosmetic medical centre. The downside is limited for NOW.
Just remember, there' s always demand no matter how ridiculously cosmetic surgery are priced because there are people who are willing and can afford it.
If you have some spare cash, looking for a 100% return, why not this stock? Of course, invest what you are prepared to lose. DYODD. (:
In my opinion, buy it when it's cheap. The company will turn profitable next year with Beverly Wilshire Group.
The Group?s quarter-on-quarter revenue for medical aesthetics increased 3646% from
S$0.041 million to S$1.536 million with only 3 months of revenue contribution from Beverly
Wilshire Group. The Group?s administrative expenses increased 97% from S$0.979 million
to S$1.927 million. The increase was mainly due to operation costs amounting to S$1.320
million arising from the newly acquired subsidiary corporations, Beverly Wilshire Medical
Centre Group. The net loss attributable to equity holders of the Company for the financial
period ended 30 September 2020 increased 2% from S$0.862 million to S$0.879 million.
The Group?s net asset value per ordinary share has maintained at positive S$0.03 cents.
Train breakdown like SMRT :P
TANPK123 ( Date: 10-Oct-2020 17:56) Posted:
|
Don't get burn by this trap guys
Director bought 50m shares again. Woohoo 👍
and it's 2 big sellers at 0.001
Who is unloading? Hohoho
ThankYou ( Date: 13-Oct-2020 08:50) Posted:
|
57M at 0.1 cent
194M at 0.2 cent
I think even if results out, only possible to sell at 0.1 cent.
194M at 0.2 cent
I think even if results out, only possible to sell at 0.1 cent.
TheMysteryDay024 ( Date: 12-Oct-2020 17:02) Posted:
|
Last call to buy in for Potential Massive Q3 results!
Train is moving soon.. standby....
Inspiring story about Ang Kok Huan (Exec Director), we should stop whinning and nothing is impossible as long as you put your heart to it:
https://dayre.me/story/e1d9cd2b7e
https://dayre.me/story/e1d9cd2b7e
Then don' t get involve yourself with such stocks. If you have cash that is ready to lose 100% then consider buying. Otherwise, stay away!
darkhorse88 ( Date: 09-Oct-2020 11:33) Posted:
|
If I have spare cash that can take 100% loss
TheMysteryDay024 ( Date: 09-Oct-2020 10:13) Posted:
|
You should also ask yourself, " who' s buying lately tho?" While I don' t deny the risks involved in this stock, but if you have some spare cash, buying at $0.001 is a bargain. Q3 results coming is around 28 days around from now.
darkhorse88 ( Date: 09-Oct-2020 09:10) Posted:
|
Who is selling though?